Table 10.
NanoString probeset ID | Genes included in each predictive model |
||||||||
---|---|---|---|---|---|---|---|---|---|
NC vs. SZ/BD |
NC vs. SZ |
NC vs. BD |
SZ vs. BD |
||||||
Affymetrix ID | NanoString | Affymetrix ID | NanoString | Affymetrix ID | NanoString | Affymetrix ID | NanoString | ||
2537112_SH3YL1 (30) | x | x | x | x | |||||
2537128_SH3YL1 (61) | x | x | x | ||||||
2647124_CPA3 (65) | x | x | x | x | |||||
2647119_CPA3 (69) | 2647109 | x | x | x | x | ||||
3554833_CRIP2 (68) | x | x | 3554818 | ||||||
2418590_SLC44A5 (51) | 2418570 | x | 2418570 | x | |||||
2661997_OXTR (43) | 2661992 | 2661992 | x | 2661992 | x | ||||
2906733_TREML4 (62) | 2906720 | x | |||||||
3063538_TRIM4 (52) | 3063536 | x | x | x | |||||
2723770_TBC1D1 (55) | x | ||||||||
3195045_PTGDS (59) | 3195034 | x | x | 3195034 | x | x | |||
2401362_TCEA3 (70) | 2401347 | x | |||||||
3667896,97_HPR | 3667890 | ||||||||
3908171_ZMYND8 | 3908149 | ||||||||
2545100_HADHA | 2545092 | ||||||||
2739191_CCDC109B | 2739160 | ||||||||
3846545_EEF2 | 3846538 | ||||||||
3333251,56,58,62,69,70,74_FADS2 | 3333247 | 3333247 | |||||||
4048243,52_HLA-DRB5 | 4048241 | ||||||||
3329128_GYLTL1B | 3329099 | ||||||||
2660633,41_IL5RA | 2660617 | ||||||||
3766938_DDX5 | 3766893 | ||||||||
AUC1 | 0.994 | 0.913 | 0.954 | 0.990 | 0.974 | 0.953 | 0.998 | 0.905 | |
Visit 2 sensitivity | 93.3% | 98.3% | 96.7% | 96.6% | 96.7% | 89.3% | 96.7% | 86.2% | |
Visit 2 specificity | 100% | 75.0% | 83.3% | 96.4% | 86.7% | 92.9% | 100% | 82.1% | |
Visit 4 sensitivity | 96.7% | 87.5% | 100% | 75.0% | 93.3% | 75.0% | 96.7% | 57.1% | |
Visit 4 specificity | 93.3% | 60.0% | 80% | 80.0% | 100.0% | 76.0% | 100% | 85.7% | |
Visit 2/4 agreement | 93.3% | 77.6% | 86.7% | 76.0% | 88.3% | 75.5% | 100% | 64.2% |
BD, bipolar disorder; SZ, schizophrenia; NC, normal control.
The AUC was for combined visit 2 and 4 modeling, and each visit was evaluated for predictions individually.